Skip to content
DraconiticResearch
Search Sources API
210,049 studies31 sourcesUpdated 59 min ago

Oncology

5,302 studies557 in 7 days2,546 in 30 days

Filters
Type
Date
Clear

Latest

5,302 studies

  1. A systematic review and dose-response meta-analysis of prospective cohort studies on body mass index and leukemia incidence and mortality
    Mohammad-Javad Abdolkarimi, Abbas Hajifathali, Reza Amiri Khosroshahi +6
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textOncologyCrossref
  2. Prevalence and geographical distribution of persons with albinism (PWA) in Togo in 2024
    Malanna Bigma, Kparakate Kota-Mamah, Rodion Yao Konu +6
    PLOS OnePeer-reviewedCC BY 4.0Full textEpidemiology & public healthOncologyPLOSHAL
  3. Personalized genomic landscape of prostate cancer in African American men reveals novel drivers and therapeutic opportunities
    Shanta Murthy, Katie Fago, James Knight +5
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPLOS
  4. Digital patient decision aids for cancer prevention in socially disadvantaged women: A scoping review protocol
    Emmanuelle Lüthi, Océane Pittet, Joanna Montagnese +5
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPLOS
  5. Survival and disease burden of breast cancer (Monastir, Tunisia): A population-based cohort study (2002–2022)
    Imen Zemni, Amani Maatouk, Wiem Boufrikha +17
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPhysiologyPLOS
  6. An operational key performance indicator framework and reference data from a multi-room pencil beam scanning proton therapy center
    Jatinder Saini, Tony Wong, Marco Schwarz +4
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPhysiologyPLOS
  7. Brain tumor segmentation using a combination of graph cut and optimized U-Net with genetic algorithm: An efficient hybrid framework for enhanced medical image analysis
    Reem M. Mostafa, Emad Mabrouk, Mohamed Saed Salim +2
    PLOS OnePeer-reviewedCC BY 4.0Full textMedical imaging & radiologyOncologyPLOS
  8. Dietary and lifestyle quality and endometrial cancer: Incidence and survivorship outcomes—An umbrella review of systematic reviews and meta-analyses
    Ruqaiya Al Ramadhani, Newshaw Arvin, Saphy Moussa +3
    PLOS OnePeer-reviewedCC BY 4.0Full textEpidemiology & public healthNutritionOncologyPLOS
  9. Real-world before-and-after evaluation of AI support for lung cancer diagnosis at three US lung nodule clinics
    Kenneth Adam Lee, Amit Borah, Garrett Fiscus +6
    PLOS OnePeer-reviewedCC BY 4.0Full textMedical imaging & radiologyOncologyPLOS
  10. Breast cancer burden risk attribution and productivity loss in Chinese women aged 25 to 49
    Yang Bai, Jiaqi Zhang, Tian Tian +2
    iSciencePeer-reviewedCC BY 4.0Full textEpidemiology & public healthOncologyCell PressCrossrefEurope PMC
  11. ATG16L2 as a prognostic biomarker and therapeutic target in kidney renal clear cell carcinoma
    Xiaoqun Xu, Chaofeng Zhou, Rui Zhang +2
    iSciencePeer-reviewedCC BY-NC-ND 4.0Full textOncologyCell PressCrossrefEurope PMC
  12. Intratumoral co-activation of ERV transcription and RNA virus-sensing is associated with radiotherapy-induced immune response and abscopal effect
    Stella Logotheti, Elif Yıldız, Sarah Hasan +7
    NPJ Precision OncologyPeer-reviewedCC BY 4.0Full textOncologyPMC
  13. CRISPRa screen unveils noncanonical NF-κB to boost the antitumor activity of TCR-based CAR-T cells
    Hanyang Yu, Yingxin Wu, Yue Liu +5
    Cellular and Molecular ImmunologyPeer-reviewedLicence not statedFull textOncologyPMC
  14. Cost-Effectiveness of AI-Powered Decentralized Production for Advanced Therapies in the Hospital–Generated Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma From a German Hospital Perspective: Early Health Technology Assessment Study
    Iris W A Boot, Anna Louisa Weltin, Ysanne de Graaf +1
    JMIR CancerPeer-reviewedCC BY 4.0Full textOncologyPMC
  15. CRISPR-Cas9 screen identifies eIF4G2 as a regulator of CD8+ T cell dysfunction
    Erin A Holcomb, Long Jiang, Ashley N Pearson +18
    The Journal of Immunology Author ChoicePeer-reviewedPublisher termsFull textOncologyPMC
  16. Symptom Management Following Radioactive Iodine Treatment in Adults With Thyroid Cancer: Usability Evaluation and Proof-of-Concept Study
    Alaina Carr, Angela M Jenkins, Valeria Gómez +7
    JMIR CancerPeer-reviewedCC BY 4.0Full textOncologyPMC
  17. Risk factors for inadequate bowel preparation and quality improvement strategies in colonoscopy: a narrative review
    Shanshan Ma, Xinyu Zhou
    Frontiers in SurgeryPeer-reviewedCC BY 4.0Full textOncologyPMC
  18. Pancreatic acinar cell carcinoma demonstrates marked clinical heterogeneity and recurrent actionable genomic alterations
    Noor Farhoud, Raed Al-Rajabi, Joaquina Baranda +15
    Frontiers in Cell and Developmental BiologyPeer-reviewedCC BY 4.0Full textOncologyPMC
  19. Exploratory predictive value of novel inflammatory biomarkers for microvascular obstruction after emergency revascularization in STEMI patients
    Yang Dai, Longjin Chen, Zhe Zhang +6
    Frontiers in MedicinePeer-reviewedCC BY 4.0Full textOncologyPMC
  20. Beyond mutation burden: biological termination as a systems perspective on cancer.
    Ivan Shterev Donev, Mila Petrova Petrova, Mariyana Ilieva Eneva +2
    Frontiers in cell and developmental biologyPeer-reviewedCC BYFull textOncologyEurope PMCPMC
  21. Engineering next-generation CAR-NK cells for hematological malignancies: genome editing, synthetic biology, and precision immunotherapy.
    Ahmed Reda Bahr, Youssef Basem, Amani Alhejely +5
    Frontiers in genome editingPeer-reviewedCC BYFull textOncologyEurope PMCPMC
  22. Trachea, bronchus, and lung cancer in women of reproductive age: global burden trends from 1990 to 2021 and forecasts to 2035.
    Shan Chen, Yao Rao, Yaohua Chen +6
    Frontiers in global women's healthPeer-reviewedCC BYFull textOncologyEurope PMCPMC
  23. Red blood cell distribution width and all-cause mortality in low-income populations: a NHANES-based cohort study.
    Hui Ma, Yu-Han Li, Jin-Da Zhao +2
    Frontiers in epidemiologyPeer-reviewedCC BYFull textOncologyEurope PMCPMC
  24. Spatial lipidomics in gynecologic malignancies: molecular identification, cellular attribution, and mechanistic validation.
    Jingyan Zhao, Wei Ma
    Frontiers in molecular biosciencesPeer-reviewedCC BYFull textOncologyEurope PMCPMC
  25. Adaptive MR-guided whole-pelvic SBRT with or without focal intraprostatic lesion boost for high-risk localized prostate Cancer: Adverse events and longitudinal quality-of-life outcomes
    Darren M.C. Poon, Jing Yuan, Bin Yang +7
    Clinical and Translational Radiation OncologyPeer-reviewedCC BY-NC-NDFull textOncologyDOAJEurope PMCEurope PMCPMC